NCT04556864 is a clinical trial in Covid19, sponsored by Juan Victor Lorente.

Who is sponsoring NCT04556864?

NCT04556864 is sponsored by Juan Victor Lorente.

What condition does NCT04556864 study?

NCT04556864 studies Covid19, Hemodynamic Instability, ARDS, Human.

Is NCT04556864 still recruiting?

NCT04556864 is currently status unknown. Last updated 21 September 2020.

Last reviewed 2020-09-21 · How we verify

NCT04556864

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19

Status unknown Last updated 21 September 2020

What this trial tests

trial in Covid19 in 67 participants. Status unknown.

Timeline

1 October 2020

Primary endpoint
30 December 2020

1 April 2021

Quick facts

Lead sponsor	Juan Victor Lorente
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	67
Start date	1 October 2020
Primary completion	30 December 2020
Estimated completion	1 April 2021
Sites	5 locations across Spain

Conditions studied

Covid19 — all drugs for Covid19 →
Hemodynamic Instability — all drugs for Hemodynamic Instability →
ARDS, Human — all drugs for ARDS, Human →

Sponsor

Juan Victor Lorente

Who can join

18 and older, any sex, with Covid19 or Hemodynamic Instability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present work is to describe the hemodynamic effects shown in patients with ARDS secondary to SARS-CoV-2 infection

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Juan Victor Lorente trials

Trials by the same sponsor.

NCT04301102 — The Predict H Trial · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04556864 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Juan Victor Lorente
Last refreshed: 21 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04556864.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing